製品名
MILLIPLEX® Human Interferon Panel,
Quality Level
description
Configurable Human Interferon 9-Plex Panel
usage
kit sufficient for 96 wells
species reactivity
human
packaging
pkg of 1 ea
manufacturer/tradename
Milliplex®
parameter
25 μL sample volume (per well)
technique(s)
multiplexing: suitable
input
serum
plasma
cell culture supernatant(s)
detection method
fluorometric (Luminex® xMAP® technology)
shipped in
wet ice
storage temp.
2-8°C
General description
Application
Analytes included: IFNα-2, IFNβ, IFNε, IFNɣ, IFNɣ Receptor 1, IFNλ1, IFNλ2, IFNλ3, IFNΩ
Assay Characteristics: Refer to kit protocol for assay cross-reactivity, sensitivity, precision, and accuracy.
Features and Benefits
- Comprehensive Interferon Coverage: Simultaneously quantify all three interferon types (Type I, II, and III) including IFNα-2, IFNβ, IFNε, IFNγ, IFNγ Receptor 1, IFNλ1, IFNλ2, IFNλ3, and IFNψ in a single assay for complete interferon profile analysis.
- Cost-Effective Sample Utilization: Maximize research efficiency by analyzing multiple interferon biomarkers from minimal sample volumes, reducing sample requirements for serum, plasma, tissue/cell lysate, and culture supernatant studies.
- Verified Cross-Reactivity Performance: Achieve reliable results with negligible cross-reactivity between antibodies, ensuring accurate quantification of individual interferon analytes for precise inflammation and immunology research.
- Viral Infection Research: Investigate the first line of defense against viral infections by simultaneously measuring type I and III interferons (IFNα-2, IFNβ, IFNε, IFNλ1, IFNλ2, IFNλ3, IFNψ) involved in antiviral host defense mechanisms.
- Cancer Immunosurveillance Studies: Analyze interferon-mediated tumor control mechanisms by quantifying IFNγ and interferon receptor expression, supporting malignant cell immunosurveillance research and cancer immunotherapy development.
Legal Information
Disclaimer
Label License/Sticker for Assay Product:
By opening the packaging containing this Assay Product (which contains fluorescently labeled microsphere beads authorized by Luminex Corporation) or using this Assay Product in any manner, you are consenting and agreeing to be bound by the End User Terms and Conditions and the End User License Agreement available at http://support.diasorin.com/end-user-terms-and-conditions/. If you do not agree to all of the terms and conditions, you must promptly return this Assay Product for a full refund prior to using it in any manner.
signalword
Danger
Hazard Classifications
Acute Tox. 3 Dermal - Acute Tox. 4 Inhalation - Acute Tox. 4 Oral - Aquatic Chronic 2 - Eye Dam. 1 - Skin Sens. 1 - STOT RE 2
target_organs
Respiratory Tract
保管分類
6.1C - Combustible acute toxic Cat.3 / toxic compounds or compounds which causing chronic effects
wgk
WGK 3
適用法令
試験研究用途を考慮した関連法令を主に挙げております。化学物質以外については、一部の情報のみ提供しています。 製品を安全かつ合法的に使用することは、使用者の義務です。最新情報により修正される場合があります。WEBの反映には時間を要することがあるため、適宜SDSをご参照ください。
Please refer to KIT Component information
pdsc
Please refer to KIT Component information
prtr
Please refer to KIT Component information
fsl
Please refer to KIT Component information
ishl_indicated
Please refer to KIT Component information
ishl_notified
Please refer to KIT Component information
cart
キットコンポーネントの情報を参照してください
jan
試験成績書(COA)
製品のロット番号・バッチ番号を入力して、試験成績書(COA) を検索できます。ロット番号・バッチ番号は、製品ラベルに「Lot」または「Batch」に続いて記載されています。
関連コンテンツ
Explore how to select the best immunoassay platform for your research by choosing between multiplex and singleplex biomarker detection assays, immunoassay instrument platforms, immunoassay software, and services.
Immunology multiplex assays, like MILLIPLEX® assays, allow researchers to investigate more immune biomarkers simultaneously, saving time and resources.
Discover the benefits of MILLIPLEX® multiplex assays, based on Luminex® xMAP® multiplex assay technology, that provide consistent, high-quality results and see how these multiplex biomarker Luminex® assays are being used to advance research.



